Financhill
Back

Spyre Therapeutics Vs. First Solar Industry Stock Comparison

Sell
25

SYRE
Spyre Therapeutics

Last Price:
23.84
Seasonality Move:
8.08%
Sell
44

FSLR
First Solar

Last Price:
216.83
Seasonality Move:
5.16%
Sell
25
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $23.79. The Score for SYRE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
First Solar (FSLR) is a Sell

Is First Solar a Buy, Sell or Hold?

  • The current First Solar [FSLR] share price is $216.73. The Score for FSLR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FSLR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $23.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.

FSLR Stock Price Chart

What is First Solar's stock price today?

  • The First Solar share price today is $216.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FSLR is experiencing selling pressure, which indicates risk of future bearish movement.

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.08 Sell
Relative Strength Index (14 RSI): 34.26 Sell
Chaikin Money Flow: -191676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.61 - 35.35) Sell
Bollinger Bands (100): (26.91 - 39.25) Sell

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.8 Sell
Relative Strength Index (14 RSI): 33.18 Sell
Chaikin Money Flow: -2034349 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (244.62 - 285.22) Sell
Bollinger Bands (100): (149.35 - 241.95) Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.65 Buy
20-day SMA: 28.94 Sell
50-day SMA: 32.57 Sell
200-day SMA: 24.7 Sell
8-day EMA: 24.52 Sell
20-day EMA: 27.6 Sell
50-day EMA: 30.92 Sell
200-day EMA: 26.88 Sell

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 242.44 Sell
20-day SMA: 262.17 Sell
50-day SMA: 230.58 Sell
200-day SMA: 175.01 Buy
8-day EMA: 238.48 Sell
20-day EMA: 249.33 Sell
50-day EMA: 233.85 Sell
200-day EMA: 191.23 Buy

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

First Solar Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.82 per share, an increase next quarter of $0.92 per share, an increase this year of $5.78 per share, and an increase next year of $8.27 per share.

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Solar Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):